FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282827068> ?p ?o ?g. }

• W4282827068 abstract "Tumor necrosis factor (TNF) receptor-2 (TNFR2) has attracted considerable interest as a target for immunotherapy. Indeed, using oligomeric fusion proteins of single chain-encoded TNFR2-specific TNF mutants (scTNF80), expansion of regulatory T cells and therapeutic activity could be demonstrated in various autoinflammatory diseases, including graft-versus-host disease (GvHD), experimental autoimmune encephalomyelitis (EAE) and collagen-induced arthritis (CIA). With the aim to improve the in vivo availability of TNFR2-specific TNF fusion proteins, we used here the neonatal Fc receptor (FcRn)-interacting IgG1 molecule as an oligomerizing building block and generated a new TNFR2 agonist with improved serum retention and superior in vivo activity.Single-chain encoded murine TNF80 trimers (sc(mu)TNF80) were fused to the C-terminus of an in mice irrelevant IgG1 molecule carrying the N297A mutation which avoids/minimizes interaction with Fcγ-receptors (FcγRs). The fusion protein obtained (irrIgG1(N297A)-sc(mu)TNF80), termed NewSTAR2 (New selective TNF-based agonist of TNF receptor 2), was analyzed with respect to activity, productivity, serum retention and in vitro and in vivo activity. STAR2 (TNC-sc(mu)TNF80 or selective TNF-based agonist of TNF receptor 2), a well-established highly active nonameric TNFR2-specific variant, served as benchmark. NewSTAR2 was assessed in various in vitro and in vivo systems.STAR2 (TNC-sc(mu)TNF80) and NewSTAR2 (irrIgG1(N297A)-sc(mu)TNF80) revealed comparable in vitro activity. The novel domain architecture of NewSTAR2 significantly improved serum retention compared to STAR2, which correlated with efficient binding to FcRn. A single injection of NewSTAR2 enhanced regulatory T cell (Treg) suppressive activity and increased Treg numbers by > 300% in vivo 5 days after treatment. Treg numbers remained as high as 200% for about 10 days. Furthermore, a single in vivo treatment with NewSTAR2 upregulated the adenosine-regulating ectoenzyme CD39 and other activation markers on Tregs. TNFR2-stimulated Tregs proved to be more suppressive than unstimulated Tregs, reducing conventional T cell (Tcon) proliferation and expression of activation markers in vitro. Finally, singular preemptive NewSTAR2 administration five days before allogeneic hematopoietic cell transplantation (allo-HCT) protected mice from acute GvHD.NewSTAR2 represents a next generation ligand-based TNFR2 agonist, which is efficiently produced, exhibits improved pharmacokinetic properties and high serum retention with superior in vivo activity exerting powerful protective effects against acute GvHD." @default.
• W4282827068 created "2022-06-15" @default.
• W4282827068 creator A5000366270 @default.
• W4282827068 creator A5014165424 @default.
• W4282827068 creator A5016360607 @default.
• W4282827068 creator A5018575155 @default.
• W4282827068 creator A5022446406 @default.
• W4282827068 creator A5025301563 @default.
• W4282827068 creator A5035182209 @default.
• W4282827068 creator A5041527718 @default.
• W4282827068 creator A5052651531 @default.
• W4282827068 creator A5064341975 @default.
• W4282827068 creator A5064885178 @default.
• W4282827068 creator A5069434242 @default.
• W4282827068 creator A5081274604 @default.
• W4282827068 creator A5084055425 @default.
• W4282827068 creator A5091873826 @default.
• W4282827068 creator A5088107424 @default.
• W4282827068 date "2022-06-13" @default.
• W4282827068 modified "2023-10-16" @default.
• W4282827068 title "A TNFR2-Specific TNF Fusion Protein With Improved In Vivo Activity" @default.
• W4282827068 cites W1499979791 @default.
• W4282827068 cites W1827799370 @default.
• W4282827068 cites W1885103044 @default.
• W4282827068 cites W1912996546 @default.
• W4282827068 cites W1975291295 @default.
• W4282827068 cites W2010438746 @default.
• W4282827068 cites W2024992774 @default.
• W4282827068 cites W2025809313 @default.
• W4282827068 cites W2038780435 @default.
• W4282827068 cites W2048834137 @default.
• W4282827068 cites W2085581000 @default.
• W4282827068 cites W2086255604 @default.
• W4282827068 cites W2096199583 @default.
• W4282827068 cites W2113601375 @default.
• W4282827068 cites W2119991694 @default.
• W4282827068 cites W2123249923 @default.
• W4282827068 cites W2127451431 @default.
• W4282827068 cites W2142850882 @default.
• W4282827068 cites W2151266657 @default.
• W4282827068 cites W2154417651 @default.
• W4282827068 cites W2157094981 @default.
• W4282827068 cites W2162124617 @default.
• W4282827068 cites W2163862604 @default.
• W4282827068 cites W2164154109 @default.
• W4282827068 cites W2168444413 @default.
• W4282827068 cites W2168707849 @default.
• W4282827068 cites W2325615207 @default.
• W4282827068 cites W2397430022 @default.
• W4282827068 cites W2473256718 @default.
• W4282827068 cites W2482400720 @default.
• W4282827068 cites W2516298309 @default.
• W4282827068 cites W2522439407 @default.
• W4282827068 cites W2531113777 @default.
• W4282827068 cites W2577169348 @default.
• W4282827068 cites W2763907629 @default.
• W4282827068 cites W2791107270 @default.
• W4282827068 cites W2794085649 @default.
• W4282827068 cites W2911840604 @default.
• W4282827068 cites W2919758335 @default.
• W4282827068 cites W2920841706 @default.
• W4282827068 cites W2930966192 @default.
• W4282827068 cites W2951700136 @default.
• W4282827068 cites W2967289515 @default.
• W4282827068 cites W2969737775 @default.
• W4282827068 cites W2977721298 @default.
• W4282827068 cites W3003852575 @default.
• W4282827068 cites W3087749555 @default.
• W4282827068 cites W3137766382 @default.
• W4282827068 cites W3157013657 @default.
• W4282827068 cites W3186169927 @default.
• W4282827068 cites W3203771154 @default.
• W4282827068 cites W3216678106 @default.
• W4282827068 cites W4200590725 @default.
• W4282827068 doi "https://doi.org/10.3389/fimmu.2022.888274" @default.
• W4282827068 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35769484" @default.
• W4282827068 hasPublicationYear "2022" @default.
• W4282827068 type Work @default.
• W4282827068 citedByCount "9" @default.
• W4282827068 countsByYear W42828270682022 @default.
• W4282827068 countsByYear W42828270682023 @default.
• W4282827068 crossrefType "journal-article" @default.
• W4282827068 hasAuthorship W4282827068A5000366270 @default.
• W4282827068 hasAuthorship W4282827068A5014165424 @default.
• W4282827068 hasAuthorship W4282827068A5016360607 @default.
• W4282827068 hasAuthorship W4282827068A5018575155 @default.
• W4282827068 hasAuthorship W4282827068A5022446406 @default.
• W4282827068 hasAuthorship W4282827068A5025301563 @default.
• W4282827068 hasAuthorship W4282827068A5035182209 @default.
• W4282827068 hasAuthorship W4282827068A5041527718 @default.
• W4282827068 hasAuthorship W4282827068A5052651531 @default.
• W4282827068 hasAuthorship W4282827068A5064341975 @default.
• W4282827068 hasAuthorship W4282827068A5064885178 @default.
• W4282827068 hasAuthorship W4282827068A5069434242 @default.
• W4282827068 hasAuthorship W4282827068A5081274604 @default.
• W4282827068 hasAuthorship W4282827068A5084055425 @default.
• W4282827068 hasAuthorship W4282827068A5088107424 @default.
• W4282827068 hasAuthorship W4282827068A5091873826 @default.
• W4282827068 hasBestOaLocation W42828270681 @default.
• W4282827068 hasConcept C104317684 @default.

• next